CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
Lysine +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04417218
NCT04417218N/ACompleted
CompareCT.gov

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2

Vanderbilt University Medical Center·interventional·Posted Jun 4, 2020·Updated Dec 21, 2023

In Brief

A clinical study evaluating Lysine and Controlled Diet for Healthy. Completed, enrolled 67 participants across 1 site.

Detailed Summary

This study aims to assess the effect of controlled dietary lysine intake on plasma and urine α-aminoadipic acid (2-AAA).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 4, 2020
Enrollment StartAug 17, 2020
Primary CompletionJan 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 6.1 years ago

Interventions

Lysinedietary

Lysine is an essential amino acid which is acquired from dietary sources.

Controlled Dietdietary

Individuals will be instructed to consume specific foods, to adhere to a controlled lysine diet.